HBLCX | WHGIX | HBLCX / WHGIX | |
Total Expense Ratio | 1.64 | 0.84 | 195% |
Annual Report Gross Expense Ratio | 1.64 | 0.84 | 195% |
Fund Existence | 19 years | 20 years | - |
Gain YTD | 7.796 | 9.383 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 100000 | 2% |
Min. Initial Investment IRA | 2000 | N/A | - |
Net Assets | 11.8B | 547M | 2,157% |
Annual Yield % from dividends | 2.58 | 3.63 | 71% |
Returns for 1 year | 1.41 | 8.48 | 17% |
Returns for 3 years | 23.03 | 40.76 | 56% |
Returns for 5 years | 11.41 | 15.11 | 75% |
Returns for 10 years | 34.61 | 16.72 | 207% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 30.65 | 1.42 | +4.87% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
ISCF | 40.84 | 0.23 | +0.57% |
iShares MSCI Intl Small-Cap Mltfct ETF | |||
EMLC | 25.43 | 0.08 | +0.32% |
VanEck JPMorgan EMLcl Ccy Bd ETF | |||
PAI | 12.70 | -0.07 | -0.55% |
Western Asset Investment Grade Income Fund | |||
XBTY | 16.61 | -0.32 | -1.89% |
GraniteShares YieldBOOST Bitcoin ETF |